Clinical Trial Update: A Study Evaluating Botulinum Toxin Type A in Subjects With Postherpetic Neuralgia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating botulinum toxin type A for postherpetic neuralgia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Allergan | Conditions: Postherpetic Neuralgia | Phase 2 | Status: COMPLETED